These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19376174)

  • 21. Light-activated RNA interference.
    Shah S; Rangarajan S; Friedman SH
    Angew Chem Int Ed Engl; 2005 Feb; 44(9):1328-32. PubMed ID: 15643658
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular transplantation: delivery of membranous proteins onto live cells.
    Orita M; Masuko-Hongo K; Yotsuyanagi H; Matsui T; Suzuki-Kurokawa M; Nishioka K; Kato T
    Anal Biochem; 2005 May; 340(1):184-6. PubMed ID: 15802147
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting specific cell types with silencing RNA.
    Williams BR
    N Engl J Med; 2005 Sep; 353(13):1410-1. PubMed ID: 16192490
    [No Abstract]   [Full Text] [Related]  

  • 24. A multifunctional magnetic nanocarrier bearing fluorescent dye for targeted drug delivery by enhanced two-photon triggered release.
    Banerjee SS; Chen DH
    Nanotechnology; 2009 May; 20(18):185103. PubMed ID: 19420604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels.
    Krebs MD; Jeon O; Alsberg E
    J Am Chem Soc; 2009 Jul; 131(26):9204-6. PubMed ID: 19530653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier PNA for shRNA delivery into cells.
    Kitamatsu M; Kubo T; Matsuzaki R; Endoh T; Ohtsuki T; Sisido M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3410-3. PubMed ID: 19481448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light-activated RNA interference in human embryonic stem cells.
    Huang X; Hu Q; Braun GB; Pallaoro A; Morales DP; Zasadzinski J; Clegg DO; Reich NO
    Biomaterials; 2015 Sep; 63():70-9. PubMed ID: 26086448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding RNA silencing approaches by U1 adaptors.
    Grünweller A; Hartmann RK
    Chembiochem; 2009 Jul; 10(10):1599-601. PubMed ID: 19533720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron-specific RNA interference using lentiviral vectors.
    Nielsen TT; Marion Iv; Hasholt L; Lundberg C
    J Gene Med; 2009 Jul; 11(7):559-69. PubMed ID: 19434604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of RNA delivery to cells by thiazole orange as a fluorescent RNA base substitution.
    Berndl S; Breunig M; Göpferich A; Wagenknecht HA
    Org Biomol Chem; 2010 Mar; 8(5):997-9. PubMed ID: 20165788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference: emerging diagnostics and therapeutics tool.
    Shrey K; Suchit A; Nishant M; Vibha R
    Biochem Biophys Res Commun; 2009 Aug; 386(2):273-7. PubMed ID: 19523438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral-mediated RNAi in vivo silencing of Col6a1, a gene with complex tissue specific expression pattern.
    Frka K; Facchinello N; Del Vecchio C; Carpi A; Curtarello M; Venerando R; Angelin A; Parolin C; Bernardi P; Bonaldo P; Volpin D; Braghetta P; Bressan GM
    J Biotechnol; 2009 Apr; 141(1-2):8-17. PubMed ID: 19428725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A caged doxycycline analogue for photoactivated gene expression.
    Cambridge SB; Geissler D; Keller S; Cürten B
    Angew Chem Int Ed Engl; 2006 Mar; 45(14):2229-31. PubMed ID: 16506298
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of antiatherosclerosis in carotid artery by RNAi-mediated silencing of MCP-1 expression.
    Hu ZJ; Liao Y; Hu LY; Wang JL; Li J; Lu WM; Wang SM
    Ann Vasc Surg; 2009; 23(5):652-62. PubMed ID: 19467827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.
    Liu XX; Rocchi P; Qu FQ; Zheng SQ; Liang ZC; Gleave M; Iovanna J; Peng L
    ChemMedChem; 2009 Aug; 4(8):1302-10. PubMed ID: 19533723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic applications of RNAi. Methods and protocols. Preface.
    Reidhaar-Olson JF; Rondinone CM
    Methods Mol Biol; 2009; 555():v-vi. PubMed ID: 19725188
    [No Abstract]   [Full Text] [Related]  

  • 37. Small silencing RNAs: state-of-the-art.
    Grimm D
    Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate conjugates: a molecular in vivo protein tag.
    Miller LW; Sable J; Goelet P; Sheetz MP; Cornish VW
    Angew Chem Int Ed Engl; 2004 Mar; 43(13):1672-5. PubMed ID: 15038033
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific knock-down of GAD67 in the striatum using naked small interfering RNAs.
    Manrique C; Compan V; Rosselet C; Duflo SG
    J Biotechnol; 2009 Jul; 142(3-4):185-92. PubMed ID: 19497341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards therapeutic application of RNA-mediated gene regulation. Preface.
    Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):667. PubMed ID: 19389435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.